Loading...

Home
ETF
NTRBW

NTRBW

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

NTRBW News

Nutriband Partners with Brand Institute to Create a Commercial Name for Its Abuse-Resistant Fentanyl Patch

Oct 10 2025Newsfilter

Nutriband Inc. Reports Record Q2 2025 Revenue Growth of 50.87% Year-Over-Year and Advances in NDA Filing for AVERSA Fentanyl

Sep 10 2025Newsfilter

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

Aug 11 2025Newsfilter

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Aug 08 2025Newsfilter

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

Jul 18 2025Newsfilter

Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030

Jun 18 2025Newsfilter

Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Jun 18 2025Newsfilter

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

Jun 09 2025Newsfilter

Nutriband CEO Publishes Letter to Shareholders

Apr 30 2025Newsfilter

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

Apr 11 2025Newsfilter

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

Apr 04 2025Newsfilter

Nutriband Signs Partnership Agreement with Charlotte FC

Apr 04 2025Newsfilter

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

Feb 21 2025Newsfilter

Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board

Feb 11 2025Newsfilter

Nutriband Issues Letter to Shareholders

Dec 31 2024Newsfilter

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Dec 27 2024Newsfilter